FDA Drug recall D-1392-2020
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acqu…
- FDA Drug
- Class III
- terminated
- Published 2020-07-29
On 2020-07-29 the FDA classified a Class III recall of Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acqu… by Hf Acquisition, citing TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1392-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-06-17 |
| Published | 2020-07-29 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Hf Acquisition |
| Distribution | CT |
Product
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12
Reason
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Identifiers
| ndc | 63323-739-11 |
|---|---|
| ndc | 63323-739-12 |
| code_info | Lot #: 6122639, Exp. Date 08/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1392-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.